Navigation Links
Scientists discover new drug target for squamous cell carcinoma
Date:5/19/2011

SEATTLE Researchers at Fred Hutchinson Cancer Research Center have discovered a new drug target for squamous cell carcinoma the second most common form of skin cancer. Scientists in the laboratory of Valeri Vasioukhin, Ph.D., have found that a protein called alpha-catenin acts as a tumor suppressor and they also have unlocked the mechanism by which this protein controls cell proliferation.

The findings by Vasioukhin and colleagues will be published May 24 in Science Signaling.

For the study, the researchers studied mice that were bred to lack a copy of the gene that makes the protein alpha-catenin in hair follicle stem cells. The researchers found that these mice developed a type of skin cancer called squamous cell carcinoma.

"The fact that alpha-catenin-deficient mice developed skin cancer led us to conclude that the loss of this protein is an important event in cancer development, and that alpha-catenin functions as a tumor suppressor," said Vasioukhin, an associate member of the Hutchinson Center's Human Biology Division. "We also found that unlike normal cells, alpha-catenin-mutant cells cannot stop dividing when they become very crowded in the Petri dish this characteristic is one of the hallmarks of cancer cells."

The researchers also teased out the mechanisms by which the protein suppresses tumor growth. They found that alpha-catenin controls the activity of a protein called Yap1, which, if activated, can cause cancer.

"We found that alpha-catenin controls cell proliferation by regulating Yap1, which is active in cells missing alpha-catenin. Therefore, Yap1 is likely to be an excellent target for the treatment of patients with squamous cell carcinoma," Vasioukhin said.

More than 700,000 new cases of squamous cell carcinoma are diagnosed each year. This form of skin cancer arises in the cells that make up most of the skin's upper layers (epidermis). Squamous cell malignancies may arise in many areas of the body including
'/>"/>

Contact: Kristen Woodward
kwoodwar@fhcrc.org
206-667-5095
Fred Hutchinson Cancer Research Center
Source:Eurekalert

Page: 1 2

Related medicine news :

1. Queens scientists teaming up to cure premature baby blindness
2. Scientists design new anti-flu virus proteins using computational methods
3. Scientists use genetically altered virus to get tumors to tattle on themselves
4. Scientists Find MRSA Germ in Supermarket Meats
5. Weizmann Institute scientists show: How adversity dulls our perceptions
6. McMaster scientists find protein’s bad guy role in prostate cancer
7. UCLA scientists discover way to amp up power of killer T cells
8. Yale and Rush University scientists receive Sanberg Awards from ASNTR
9. Scripps Research scientists show how shifts in temperature prime immune response
10. CIRM awards Scripps Research Institute scientists $3.5 million
11. Scientists afflict computers with schizophrenia to better understand the human brain
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/28/2014)... New York (PRWEB) August 28, 2014 An ... back and neck issues, Cloud 9 Spine offers their resources ... spine problems can quickly become a brick wall of discouragement ... for a professional opinion, Cloud 9 Spine offers ... proprietary technology merged with human interaction that sets Cloud 9 ...
(Date:8/28/2014)... Alpine, NJ resident Othon Mourkakos is proud to ... Tiaras, to benefit the Immune Deficiency Foundation (IDF) Walk ... in Foley Square, New York. IDF is the ... (PI) are a group of more than 200 rare, ... immune system is missing or functions improperly. In ...
(Date:8/28/2014)... The revenue cycle process touches on ... time a patient books an appointment with a physician’s ... payments for services rendered to the healthcare provider. ... has the RCM process down to a science. Over ... common place in nearly every healthcare facility around the ...
(Date:8/27/2014)... Asheville, NC (PRWEB) August 28, 2014 ... for companies to acquire as part of a ... business. Aeroflow is positioned for taking ownership of ... foundation to increase economies of scale. , Last ... an agreement with Hometown Respiratory to increase service ...
(Date:8/27/2014)... Spine Guide has built a reputation for itself ... health. Now, the e-health site will offer new surgical ... pain symptoms. Spine Guide specializes in three types of ... surgery. , Some of the most common back pain ... radiating down the leg, inability to stand up straight, ...
Breaking Medicine News(10 mins):Health News:Making Waves on the East Coast, Cloud 9 Spine is Helping Patients Find Appointments With Local Spine Doctors 2Health News:Tips on Automating the Revenue Cycle Process with Medical Billing 2Health News:Tips on Automating the Revenue Cycle Process with Medical Billing 3Health News:Aeroflow Healthcare Seeks Strategic Acquisition Opportunities 2Health News:Spine Guide Offering New Overview of Surgical Options For Back Pain 2
... Switzerland and Brussels, Belgium, 9 April 2008: The European ... European CanCer Organisation have united forces to host a ... best and most updated scientific data for everyone working ... providing all cancer patients with equal access to high-quality ...
... 2008 Ever wonder if,your doctor personally follows the ... to the recent "Life ... supplemented" Healthcare,Professionals (HCP) Impact ... behaviors, with three of the top shared healthy behaviors,being: ... regularly (73,percent) and taking vitamins and other supplements (72 ...
... Research, Programs for #1 Cause of,Fatal and Nonfatal Injuries ... A broad-based,coalition of nonprofit organizations dedicated to improving the ... of S. 845, the Safety,of Seniors (SOS) Act, clearing ... point: each year, one in three older Americans (65 ...
... counterintuitive to exercise when suffering with joint pain, but ... most people suffering from arthritis. A recent study ... regular exercise, specifically the Arthritis Foundation Exercise Program, is ... pain. This is good news for the aging ...
... April 8, 2008 The Procter &,Gamble Company (NYSE: ... in the quarterly dividend from thirty-five cents ($0.35) to forty,cents ... Series A and Series,B ESOP Convertible Class A Preferred Stock ... shareholders of record at the close of business on,April 18, ...
... Chinese studies show cancer treatment extended survival time in ... combination of the active ingredients in reishi mushrooms and ... survival time of mice with sarcomas, two Chinese studies ... fat, muscle, blood vessels, or other connective or supportive ...
Cached Medicine News:Health News:European Society for Medical Oncology and European CanCer Organization join forces 2Health News:Doctors' and Nurses' Wellness Checklist: Healthy Diet, Exercise, Dietary Supplements 2Health News:Doctors' and Nurses' Wellness Checklist: Healthy Diet, Exercise, Dietary Supplements 3Health News:Elder Falls Bill Passes Congress, Heads to President 2Health News:Elder Falls Bill Passes Congress, Heads to President 3Health News:Physical activity is natural pain reliever for arthritis 2Health News:Green Tea, Mushroom Extract Combo Slows Sarcomas 2
(Date:8/27/2014)... 2014 Kewaunee Scientific Corporation (Nasdaq: ... its quarterly cash dividend by 9% to twelve cents ... beginning with the dividend payable on September 22, 2014 ... on September 8, 2014. About Kewaunee ... Scientific Corporation is a recognized global leader in the ...
(Date:8/27/2014)... NINGBO, China , Aug. 27, 2014 /PRNewswire/ ... Co., Ltd, ("Menovo") today announced they had entered into ... primarily targeting the United States ... Menovo will jointly develop products for Amerigen to commercialize ... will be responsible for manufacturing API and finished product ...
(Date:8/27/2014)... 27, 2014 Ambit Biosciences (Nasdaq: AMBI ), ... targeting unmet needs in oncology, autoimmune and inflammatory disease, today ... Conference to be held at The New York Palace Hotel ... 3-4, 2014. Alan Fuhrman , Ambit,s CFO, ... drug candidate, quizartinib, at 1:10 p.m. ET on Wednesday, September ...
Breaking Medicine Technology:Amerigen Pharmaceuticals Limited and the Ningbo Menovo Pharmaceutical Co., Ltd, today announced they had entered into a collaboration agreement regarding the development of generic pharmaceuticals, primarily targeting the United States market 2Ambit Announces Participation At Baird 2014 Health Care Conference 2
The High Pure Viral RNA Kit is intended for general laboratory use and is designed to purify viral RNA from serum or plasma. Viral RNA is used for RT-PCR analysis directly after elution in nuclease-f...
... This revolutionary product will provide you ... type of electroretinogram, visual evoked potential, ... ganzfeld will allow you to perform ... on-off, double flash, photopic negative response, ...
The PersonalLAB junior is an automated microplate analyzer capable of fully automating immunoenzymatic techniques using a microplate format, per the reagent manufacturer's instruction for use and spe...
... is designed for high throughput microplate processing. ... S60 Stacker that handles up to 60 ... base model is equipped with a dual ... units may be interfaced to increase flexibility ...
Medicine Products: